Horan Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-51,053
Closed -$7.47M 65
2019
Q1
$7.47M Sell
51,053
-1,392
-3% -$202K 1.38% 23
2018
Q4
$7.01M Sell
52,445
-24,149
-32% -$3.96M 1.46% 23
2018
Q3
$14.6M Sell
76,594
-1,835
-2% -$337K 2.69% 15
2018
Q2
$13.1M Sell
78,429
-672
-0.8% -$108K 2.56% 17
2018
Q1
$13.3M Buy
79,101
+16,992
+27% +$2.85M 2.89% 17
2017
Q4
$10.2M Buy
62,109
+18,734
+43% +$3.36M 2.02% 18
2017
Q3
$8.89M Buy
43,375
+4,748
+12% +$1.1M 1.85% 23
2017
Q2
$9.39M Sell
38,627
-90
-0.2% -$21.1K 2.05% 20
2017
Q1
$9.25M Buy
38,717
+6,836
+21% +$1.59M 2.11% 19
2016
Q4
$6.7M Buy
+31,881
New +$6.6M 1.73% 24

Other funds holding AGN

Horan Capital Management's AGN Position: Q2 2019 in Review

Horan Capital Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 51,053 shares — an estimated $7.47M sold.

Horan Capital Management first reported a position in AGN in Q4 2016 and held it in 10 quarters. The position peaked at $14.6M in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Horan Capital Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Horan Capital Management sold 51,053 Allergan plc shares in Q2 2019, an estimated $7.47M.
  • Horan Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 10 quarters.
  • Horan Capital Management's Allergan plc position peaked at $14.6M in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Horan Capital Management's 13F filing for Q2 2019, filed 17 Jul 2019.